Home/Supreme Court/Fibrogen, Inc. v. Akebia Therapeutics, Inc.

Fibrogen, Inc. v. Akebia Therapeutics, Inc.

136 S. Ct. 1, 192 L. Ed. 2d 994, 84 U.S.L.W. 3099, 2015 U.S. LEXIS 4658, 2015 WL 5097135
Supreme Court of the United States·Decided August 31, 2015·No. No. 15A252.·Published

Opinion

ANTHONY M. KENNEDY, Associate Justice of the Supreme Court of the United States.

UPON CONSIDERATION of the application of counsel for the applicant,

IT IS ORDERED that the order of the United States District Court for the Northern District of California granting discovery is stayed pending further order of the undersigned or of the Court.

Free access — add to your briefcase to read the full text and ask questions with AI

Fibrogen, Inc. v. Akebia Therapeutics, Inc., 136 S. Ct. 1, 192 L. Ed. 2d 994, 84 U.S.L.W. 3099, 2015 U.S. LEXIS 4658, 2015 WL 5097135 (U.S. 2015).

136 S. Ct. 1 (Fibrogen, Inc. v. Akebia Therapeutics, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.